Clinical Trials · NCT05671653
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Pfizer
- Enrollment
- 32
- Start date
- Jan 2023
- Locations
- 1 site, United States
- Primary endpoint
- Cohort 1: Area Under the Plasma Concentration-Time Profile From Time 0 Extrapolated to Infinite Time (AUCinf) of Midazolam in Periods 1, 4 and 7